Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System

Boston Scientific Corporation (NYSE:BSX) is one of the 10 Best Growth Stocks to Buy for the Next Decade. Boston Scientific Corporation (NYSE:BSX) is one of the best growth stocks to buy for the next decade. On March 30, Boston Scientific received FDA 510(k) clearance for its Asurys Fluid Management System, a new technology designed to manage irrigation and distention during endoscopic urologic procedures. The system is intended for use in ureteroscopy, cystoscopy, percutaneous nephrolithotomy/PCNL, and benign prostatic hyperplasia/BPH treatments.

By providing a single irrigation management solution, the device aims to streamline clinical workflows and assist in the diagnosis and treatment of conditions such as kidney stones. A primary feature of the Asurys System is its ability to regulate irrigation inflow to help maintain low intrarenal pressure/IRP while ensuring clear visualization. When paired with the LithoVue Elite Single-Use Digital Flexible Ureteroscope, the system can automatically respond to IRP data in real-time.

This capability is designed to help physicians minimize the risk of exceeding pre-set pressure settings, which is critical for avoiding post-operative complications like sepsis or renal damage. The system also integrates irrigation control directly onto the scope handle, allowing physicians to activate an on-demand flush feature to reposition stones without manual assistance.

Boston Scientific Corporation (NYSE:BSX) is a healthcare company,  incorporated in 1979, that specializes in medical devices for interventional medical specialties. The company’s segments include MedSurg and Cardiovascular.

While we acknowledge the risk and potential of BSX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BSX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.